Tech News
← Back to articles

Novo Nordisk's new obesity pill, Alphabet's data center deal, the end of EV euphoria and more in Morning Squawk

read original related products more articles

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters

This is CNBC's Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Here are five key things investors need to know to start the trading day:

1. Trim tab

Regulators approved the first-ever pill — yes, a pill — for treating obesity yesterday. It's viewed as a landmark decision that can lead to expanded access for patients. Here's what to know: Novo Nordisk

The starting dose of 1.5 milligrams will be available at pharmacies and through select telehealth providers for $149 per month, with savings offers.

Shares of Novo Nordisk surged 7% in overnight trading. Competitor Eli Lilly,

Elsewhere, we're keeping an eye on Dominion Energy halted the wind project it was developing.

halted the wind project it was developing. Follow live markets updates here.

2. Family business

The Paramount logo is displayed on the water tower at Paramount Studios on December 8, 2025 in Los Angeles, California. Mario Tama | Getty Images

... continue reading